Myasthenia gravis, other antibodies positive (Q88647): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 14:58, 15 August 2026
Late-onset generalised Myasthenia Gravis (MG), either male or female, is associated with atrophic thymuses. Most late-onset (>50 years) patients, either male or female, are AChR positive and in addition often have anti-striational antibodies including anti-titin, ryanodine receptor (RyR), and Kv1.4 antibodies. These antibodies are associated with a severe form of MG and are more frequently found in thymoma-associated MG.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_2004419909 |
||
| English | Myasthenia gravis, other antibodies positive |
Late-onset generalised Myasthenia Gravis (MG), either male or female, is associated with atrophic thymuses. Most late-onset (>50 years) patients, either male or female, are AChR positive and in addition often have anti-striational antibodies including anti-titin, ryanodine receptor (RyR), and Kv1.4 antibodies. These antibodies are associated with a severe form of MG and are more frequently found in thymoma-associated MG. |
Statements
CID11:ID_2004419909
0 references
dki-india-ID_2004419909
0 references
Concluído
0 references
13 August 2026
0 references
